This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

29 November - 9 December, 2021
Delivered in a 100% Digital Format as a Free-to-Attend Webinar Series

Ingrid Kromann
Head of CMC at R&D CEPI


Ingrid Kromann started 01 March 2020 as Head of CMC, CEPI, UK. The CEPI CMC team is facilitating the vaccine developers in process development and scale up activities.

Ingrid has a background as chemical engineer. She has more than 25 years’ experience of working with vaccines through her employment at Statens Serum Institut, Denmark.

For the last 16 years, Ingrid led the Vaccine development department at Statens Serum Institut, and has developed more than 10 different vaccines from research to clinical trials, mostly within Tuberculosis, Polio and Chlamydia.

Agenda Sessions

  • Development and Manufacturing COVID19 Vaccines in a Pandemic Situation